Description:
Latanoproste bunod is a nitric oxide-donating prostaglandin F2α (FP) receptor agonist. Under the trade name Vyzulta, it has been approved for the treatment of intraocular pressure in patients with open-angle glaucoma or ocular hypertension in 2017.
- Molecular Weight: 507.62
- Molecular Formula: C27H41NO8
Purity: ≥95%
Canonical SMILES:
C1C(C(C(C1O)CC=CCCCC(=O)OCCCCO[N+](=O)[O-])CCC(CCC2=CC=CC=C2)O)O
InChI:
InChI=1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1
InChIKey: LOVMMUBRQUFEAH-UIEAZXIASA-N
- Boiling Point: 658.3±55.0 °C at 760 mmHg
- Appearance: Oil
Synonyms:
BOL-303259-X; NCX 116; PF-3187207
More details are to be found on supplier website
